Listed below is a selection of recent publications from the Vaughan Lab. See a complete list of Dr. Vaughan’s publications.

A Plasmodium parasite with complete late liver stage arrest protects against preerythrocytic and erythrocytic stage infection in miceVaughan AM, Sack BK, Dankwa D, Minkah N, Nguyen T, Cardamone H, Kappe SH. Infect Immun. 2018;86(5).

Plasmodium falciparum genetic crosses in a humanized mouse modelVaughan AM, Pinapati RS, Cheeseman IH, Camargo N, …Kappe SH. Nature Methods. 2015 Jul;12(7):631-3.

Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric miceVaughan AM, Mikolajczak SA, Kangwanrangsan N, Roobsoong W, Fishbaugher M, Yimamnuaychok N, Rezakhani N, Lakshmanan V, Singh N, Kaushansky A, Camargo N, Baldwin M, Lindner SE, Adams JH, Sattabongkot J, Kappe SH. Cell Host Microbe. 2015;17(4):526-35.

A Plasmodium yoelii Mei2-Like RNA binding protein is essential for completion of liver stage schizogonyDankwa DA, Davis MJ, Kappe SH, Vaughan AM. Infect Immun. 2016;84(5):1336-45.

Enzymes involved in plastid-targeted phosphatidic acid synthesis are essential for Plasmodium yoelii liver-stage developmentLindner SE, Sartain MJ, Hayes K, Harupa A, Moritz RL, Kappe SH, Vaughan AM. Mol Microbiol. 2014;91(4):679-93.

Complete Plasmodium falciparum liver-stage development in liver-chimeric miceVaughan AM, Mikolajczak SA, Wilson EM, Grompe M, Kaushansky A, Camargo N, Bial J, Ploss A, Kappe SH. J Clin Invest. 2012;122(10):3618-28. Epub 2012/09/22.

Type II fatty acid synthesis is essential only for malaria parasite late liver stage developmentVaughan AM, O’Neill MT, Tarun AS, Camargo N, Phuong TM, Aly AS, Cowman AF, Kappe SH. Cell Microbiol. 2009;11(3):506-20.